Using statins to treat 'healthy' patients: are we there yet?
Shah
Bijal M
BM
Kemp
Robert
R
Clearfield
Michael
M
D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003327:Coronary Disease / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D016527:Drug Costs; D005464:Fluorobenzenes / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D011315:Preventive Medicine / Q000191:economics / Q000639:trends*; D011743:Pyrimidines / Q000627:therapeutic use; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium